From Collapse to Comeback: Inside Biotech’s ‘Death-to-Rebirth’ Cycle
Layoffs Hit Biotech Hubs Hard In labs from Boston’s Kendall
Syngene’s Baltimore Bet: Indian Biotech’s American Ambitions and Global Supply Shake-Up
A few years ago, Emergent BioSolutions’ Bayview plant in Baltimore
Roche’s Bold Foray into Obesity Treatment: A $5.3 Billion Bet on Petrelintide
In a strategic move poised to reshape the landscape of
Breaking the Bias: How Precision Medicine Can Overcome Ancestral Disparities
In the rapidly advancing field of precision medicine, where treatments
The Billionaire Longevity Experiment: A Cruise Ship Promises to Extend Life—For a Price
For the wealthy and the wellness-obsessed, the pursuit of longevity
Tropic Unveils Gene-Edited Non-Browning Bananas to Reduce Food Waste
A New Era for Bananas: The Innovation That Could Change
AbbVie Enters Obesity Drug Market with $2.2B Gubra Licensing Deal
AbbVie, a leading biopharmaceutical company, has taken a significant step
How AI is Revolutionizing Antibiotic Discovery to Combat Drug-Resistant Bacteria
Antibiotic resistance poses a significant global health threat, rendering many
Metsera’s Weight-Loss Drug MET-097i Shows Strong Clinical Results
Obesity remains a critical public health challenge in the United
Michigan-Based Biotech Startup CircNova Secures $3.3M Seed Funding to Advance AI-Driven Circular RNA Therapies
CircNova, a Michigan-based biotechnology startup, has successfully raised $3.3 million
Illumina’s Market Struggles Deepen as U.S.-China Tensions Escalate
Illumina, a prominent biotech firm specializing in gene-sequencing technology, is
Breaking Barriers: BioArctic’s Blood-Brain Transport Technology and Its Impact on Neurological Drug Delivery
BioArctic, a Swedish biotechnology company renowned for its innovative approach
Merck KGaA in Talks to Acquire U.S. Biotech Firm SpringWorks, Valued at $4 Billion
Merck KGaA, Darmstadt, Germany, is reportedly in advanced negotiations to
Light-Based Microcapillary Monitoring Expands Precision in Biotechnology
Microcapillary technology, particularly light-based microcapillary monitoring, represents a significant advancement
Draupnir Bio Raises €12 Million to Advance Oral Protein Degraders Targeting Extracellular Proteins
Draupnir Bio, a cutting-edge biotechnology company, has successfully raised €12
Novo Holdings Leads $100 Million Series C Financing for Asceneuron
Novo Holdings has led a $100 million Series C financing
German Biotech CatalYm Raises $150 Million for Phase 2b Cancer Studies
CatalYm, a German biotech company specializing in cancer immunotherapy, has
Myricx Bio’s NMTi-ADCs Achieve Tumor Regression in Preclinical Trials
The field of cancer treatment is on the cusp of
Pharma Giant Eli Lilly to Buy Biotech Firm Morphic for $3.2 Billion
Eli Lilly and Company, a global leader in pharmaceutical development,
Brisbane Biotech Gelomics Raises $2.2 Million in Pre-Seed Funding
In a significant stride towards ethical biomedical advancements, Brisbane-based biotech
Alumis IPO Priced at $16, Targets $210M Funding
Alumis, a clinical-stage immunology biotech company, has priced its downsized
Unlocking New Frontiers: How Generative AI is Transforming Protein Design and Drug Discovery
Abstract This report explores the transformative impact of generative artificial
